JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B5860 TAK960

Target: PLK

Summary: Oral and selective PLK1 inhibitor

≥28.05 mg/mL
B5863 LX7101 HCL

Summary: Dual LIM-kinase and ROCK inhibitor

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
B5879 GSK2879552
1 Citation

Target: LSD

Summary: Novel and irreversible LSD1 inhibitor

insoluble in EtOH; ≥10.14 mg/mL
B1066 Dolastatin 10 trifluoroacetate

Summary: Antitumor agent

Soluble in DMSO
A8898 HZ-1157

Summary: HCV NS3/4A protease inhibitor

insoluble in H2O; ≥11.6 mg/mL
L1045 DiscoveryProbe™ TGF-beta/Smad Compound Library

Summary: A unique collection of 88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research.
A7088 L-NAME hydrochloride
5 Citation

Summary: NO synthase inhibitor

≥27 mg/mL
A1032 Adrenorphin

Summary: Endogenous μ/κ opioid agonist,potent and selective

insoluble in EtOH; ≥48.7 mg/mL
A1036 Thrombin Receptor Activator for Peptide 5 (TRAP-5)

Target: Thrombin Receptor

Summary: Thrombin Receptor Activator for Peptide 5

insoluble in EtOH; ≥14.63 mg/mL
C6524 Laurocapram

≥26.5 mg/mL